Abiopharma

New Form 4 - NextCure, Inc. Filed: 2025-06-24 AccNo: 0000905148-25-002242 Size: 5 KB

New Form 8-K - Innovative Eyewear Inc Filed: 2025-06-24 AccNo: 0001829126-25-004680 Size: 787 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - NextCure, Inc. Filed: 2025-06-24 AccNo: 0000905148-25-002241 Size: 4 KB

New Form 4 - Candel Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0000950170-25-089473 Size: 5 KB

New Form 4 - NextCure, Inc. Filed: 2025-06-24 AccNo: 0000905148-25-002243 Size: 5 KB

New Form 8-K - Replimune Group, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-062122 Size: 190 KB Item 7.01: Regulation FD Disclosure

New Form 4 - Akari Therapeutics Plc Filed: 2025-06-24 AccNo: 0000950170-25-089462 Size: 4 KB

New Form 4 - NeuroPace Inc Filed: 2025-06-24 AccNo: 0001415889-25-018090 Size: 18 KB

New Form 4 - NeuroPace Inc Filed: 2025-06-24 AccNo: 0001415889-25-018089 Size: 16 KB

New Form 4 - NeuroPace Inc Filed: 2025-06-24 AccNo: 0001415889-25-018091 Size: 18 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001628280-25-032846 Size: 8 KB

New Form 4 - NeuroPace Inc Filed: 2025-06-24 AccNo: 0001415889-25-018088 Size: 16 KB

New Form 4 - Blueprint Medicines Corp Filed: 2025-06-24 AccNo: 0001415889-25-018086 Size: 5 KB

New Form 4 - Blueprint Medicines Corp Filed: 2025-06-24 AccNo: 0001415889-25-018084 Size: 5 KB

New Form 4 - Blueprint Medicines Corp Filed: 2025-06-24 AccNo: 0001415889-25-018082 Size: 5 KB